Download PDF
Semin Neurol 2023; 43(01): 123-146
DOI: 10.1055/s-0043-1764164
Review Article

“Unvoluntary” Movement Disorders: Distinguishing between Tics, Akathisia, Restless Legs, and Stereotypies

Christelle Nilles
1   Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Gabriel Amorelli
1   Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Tamara M. Pringsheim
2   Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
3   Mathison Centre for Mental Health Research and Education, Calgary, Alberta, Canada
4   Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
,
Davide Martino
1   Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
3   Mathison Centre for Mental Health Research and Education, Calgary, Alberta, Canada
4   Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Tics, stereotypies, akathisia, and restless legs fall at different places on the spectrum of discrete, unwanted and potentially disabling motor routines. Unlike tremor, chorea, myoclonus, or dystonia, this subgroup of abnormal movements is characterized by the subject's variable ability to inhibit or release undesired motor patterns on demand. Though it may be sometimes clinically challenging, it is crucial to distinguish these “unvoluntary” motor behaviors because secondary causes and management approaches differ substantially. To this end, physicians must consider the degree of repetitiveness of the movements, the existence of volitional control, and the association with sensory symptoms, or cognitive-ideational antecedent. This review aims to summarize the current existing knowledge on phenomenology, diagnosis, and treatment of tics, stereotypies, akathisia, and restless leg syndrome.

Keywords

tics - stereotypies - akathisia - restless legs - diagnosis - management

* These authors have equally contributed to the manuscript.




Publication History

Article published online:
28 February 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Robertson MM, Eapen V, Singer HS. et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers 2017; 3 (01) 16097
    CrossrefPubMedGoogle Scholar
  • 2 Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993; 150 (01) 98-102
    CrossrefPubMedGoogle Scholar
  • 3 Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol 2014; 13 (01) 100-112
    CrossrefPubMedGoogle Scholar
  • 4 Himle MB, Woods DW, Bunaciu L. Evaluating the role of contingency in differentially reinforced tic suppression. J Appl Behav Anal 2008; 41 (02) 285-289
    CrossrefPubMedGoogle Scholar
  • 5 Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. “Just right” perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 1994; 151 (05) 675-680
    CrossrefPubMedGoogle Scholar
  • 6 Kane MJ. Premonitory urges as “attentional tics” in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1994; 33 (06) 805-808
    CrossrefPubMedGoogle Scholar
  • 7 Friedrich J, Spaleck H, Schappert R. et al. Somatosensory perception-action binding in Tourette syndrome. Sci Rep 2021; 11 (01) 13388
    CrossrefPubMedGoogle Scholar
  • 8 Webber TA, Johnson PL, Storch EA. Pediatric misophonia with comorbid obsessive-compulsive spectrum disorders. Gen Hosp Psychiatry 2014; 36 (02) 231.e1-231.e2
    CrossrefPubMedGoogle Scholar
  • 9 Robinson S, Hedderly T, Conte G, Malik O, Cardona F. Misophonia in children with tic disorders: a case series. J Dev Behav Pediatr 2018; 39 (06) 516-522
    CrossrefPubMedGoogle Scholar
  • 10 Cheung MYC, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord 2007; 22 (12) 1743-1750
    CrossrefPubMedGoogle Scholar
  • 11 Leckman JF, Riddle MA, Hardin MT. et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28 (04) 566-573
    CrossrefPubMedGoogle Scholar
  • 12 McGuire JF, Piacentini J, Storch EA. et al. A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale. Neurology 2018; 90 (19) e1711-e1719
    CrossrefPubMedGoogle Scholar
  • 13 American Psychiatric Association.. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: DSM 5®; 2013
  • 14 Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol 2012; 47 (02) 77-90
    CrossrefPubMedGoogle Scholar
  • 15 Yang J, Hirsch L, Martino D, Jette N, Roberts J, Pringsheim T. The prevalence of diagnosed Tourette syndrome in Canada: a national population-based study. Mov Disord 2016; 31 (11) 1658-1663
    CrossrefPubMedGoogle Scholar
  • 16 Mataix-Cols D, Isomura K, Pérez-Vigil A. et al. Familial risks of Tourette syndrome and chronic tic disorders. A population-based cohort study. JAMA Psychiatry 2015; 72 (08) 787-793
    CrossrefPubMedGoogle Scholar
  • 17 Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42 (07) 436-447
    CrossrefPubMedGoogle Scholar
  • 18 Leckman JF, Zhang H, Vitale A. et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998; 102 (1, Pt 1): 14-19
    CrossrefPubMedGoogle Scholar
  • 19 Groth C, Mol Debes N, Rask CU, Lange T, Skov L. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry 2017; 56 (04) 304-312
    CrossrefPubMedGoogle Scholar
  • 20 Lichter DG, Finnegan SG. Influence of gender on Tourette syndrome beyond adolescence. Eur Psychiatry 2015; 30 (02) 334-340
    CrossrefPubMedGoogle Scholar
  • 21 Hirschtritt ME, Lee PC, Pauls DL. et al; Tourette Syndrome Association International Consortium for Genetics. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry 2015; 72 (04) 325-333
    CrossrefPubMedGoogle Scholar
  • 22 Darrow SM, Grados M, Sandor P. et al. Autism spectrum symptoms in a Tourette's disorder sample. J Am Acad Child Adolesc Psychiatry 2017; 56 (07) 610-617.e1
    CrossrefPubMedGoogle Scholar
  • 23 Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P. Understanding disability in Tourette syndrome. Dev Med Child Neurol 2009; 51 (06) 468-472
    CrossrefPubMedGoogle Scholar
  • 24 Eddy CM, Cavanna AE, Gulisano M, Calì P, Robertson MM, Rizzo R. The effects of comorbid obsessive-compulsive disorder and attention-deficit hyperactivity disorder on quality of life in Tourette syndrome. J Neuropsychiatry Clin Neurosci 2012; 24 (04) 458-462
    CrossrefPubMedGoogle Scholar
  • 25 Osland ST, Steeves TD, Pringsheim T. . Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Developmental, Psychosocial and Learning Problems Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2018(6). Accessed February 5, 2023 at: http://doi.wiley.com/10.1002/14651858.CD007990.pub3
    PubMed
  • 26 Lyon GJ, Samar SM, Conelea C. et al. Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder. J Child Adolesc Psychopharmacol 2010; 20 (04) 283-289
    CrossrefPubMedGoogle Scholar
  • 27 Cohen SC, Mulqueen JM, Ferracioli-Oda E. et al. Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2015; 54 (09) 728-736
    CrossrefPubMedGoogle Scholar
  • 28 Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002; 58 (04) 527-536
    CrossrefPubMedGoogle Scholar
  • 29 Gershanik OS, Gómez Arévalo GJ. . Typical and atypical neuroleptics. In: Handbook of Clinical Neurology [Internet]. Elsevier; 2011:579–599. Accessed February 5, 2023 at: https://linkinghub.elsevier.com/retrieve/pii/B9780444520142000422
  • 30 Madruga-Garrido M, Mir P. . Tics and other stereotyped movements as side effects of pharmacological treatment. In: International Review of Neurobiology [Internet]. Elsevier; 2013:481–294. Accessed February 5, 2023 at: https://linkinghub.elsevier.com/retrieve/pii/B9780124115460000160
  • 31 Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother 2010; 10 (06) 893-901
    CrossrefPubMedGoogle Scholar
  • 32 Ganos C, Martino D. Tics and Tourette syndrome. Neurol Clin 2015; 33 (01) 115-136
    CrossrefPubMedGoogle Scholar
  • 33 Ricketts EJ, Wu MS, Leman T, Piacentini J. A review of tics presenting subsequent to traumatic brain injury. Curr Dev Disord Rep 2019; 6 (03) 145-158
    CrossrefPubMedGoogle Scholar
  • 34 Ganos C, Al-Fatly B, Fischer JF. et al. A neural network for tics: insights from causal brain lesions and deep brain stimulation. Brain 2022; 145 (12) 4385-4397
    CrossrefPubMedGoogle Scholar
  • 35 Jankovic J, Ashizawa T. Tourettism associated with Huntington's disease. Mov Disord 1995; 10 (01) 103-105
    CrossrefPubMedGoogle Scholar
  • 36 Schrag AE, Martino D, Wang H. et al; European Multicentre Tics in Children Study (EMTICS). Lack of association of group A streptococcal infections and onset of tics: European Multicenter Tics in Children Study. Neurology 2022; 98 (11) e1175-e1183
    CrossrefPubMedGoogle Scholar
  • 37 Nilles C, Pringsheim TM, Martino D. The recent surge of functional movement disorders: social distress or greater awareness?. Curr Opin Neurol 2022; 35 (04) 485-493
    CrossrefPubMedGoogle Scholar
  • 38 Pringsheim T, Ganos C, McGuire JF. et al. Rapid onset functional tic-like behaviors in young females during the COVID-19 pandemic. Mov Disord 2021; 36 (12) 2707-2713
    CrossrefPubMedGoogle Scholar
  • 39 Müller-Vahl KR, Pisarenko A, Jakubovski E, Fremer C. Stop that! It's not Tourette's but a new type of mass sociogenic illness. Brain 2022; 145 (02) 476-480
    CrossrefPubMedGoogle Scholar
  • 40 Zea Vera A, Bruce A, Garris J. et al. The phenomenology of tics and tic-like behavior in TikTok. Pediatr Neurol 2022; 130: 14-20
    CrossrefPubMedGoogle Scholar
  • 41 Pringsheim T, Holler-Managan Y, Okun MS. et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019; 92 (19) 907-915
    CrossrefPubMedGoogle Scholar
  • 42 Andrén P, Jakubovski E, Murphy TL. et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: Psychological interventions. Eur Child Adolesc Psychiatry 2022; 31 (03) 403-423
    CrossrefPubMedGoogle Scholar
  • 43 Pringsheim T, Okun MS, Müller-Vahl K. et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019; 92 (19) 896-906
    CrossrefPubMedGoogle Scholar
  • 44 van de Griendt JMTM, Verdellen CWJ, van Dijk MK, Verbraak MJPM. Behavioural treatment of tics: habit reversal and exposure with response prevention. Neurosci Biobehav Rev 2013; 37 (06) 1172-1177
    CrossrefPubMedGoogle Scholar
  • 45 Espil FM, Woods DW, Specht MW. et al. Long-term outcomes of behavior therapy for youth with Tourette disorder. J Am Acad Child Adolesc Psychiatry 2021;(Sep):S0890856721013678
    PubMedGoogle Scholar
  • 46 Piacentini J, Woods DW, Scahill L. et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010; 303 (19) 1929-1937
    CrossrefPubMedGoogle Scholar
  • 47 Wilhelm S, Peterson AL, Piacentini J. et al. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry 2012; 69 (08) 795-803
    CrossrefPubMedGoogle Scholar
  • 48 Verdellen CWJ, Keijsers GPJ, Cath DC, Hoogduin CAL. Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther 2004; 42 (05) 501-511
    CrossrefPubMedGoogle Scholar
  • 49 Andrén P, Wachtmeister V, Franzé J. et al. Effectiveness of behaviour therapy for children and adolescents with Tourette syndrome and chronic tic disorder in a naturalistic setting. Child Psychiatry Hum Dev 2021; 52 (04) 739-750
    CrossrefPubMedGoogle Scholar
  • 50 Hollis C, Hall CL, Jones R. et al. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial. Lancet Psychiatry 2021; 8 (10) 871-882
    CrossrefPubMedGoogle Scholar
  • 51 Andrén P, Holmsved M, Ringberg H. et al. Therapist-supported Internet-delivered exposure and response prevention for children and adolescents with Tourette syndrome: a randomized clinical trial. JAMA Netw Open 2022; 5 (08) e2225614
    CrossrefPubMedGoogle Scholar
  • 52 Roessner V, Eichele H, Stern JS. et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: Pharmacological treatment. Eur Child Adolesc Psychiatry 2022; 31 (03) 425-441
    CrossrefPubMedGoogle Scholar
  • 53 American Academy of Neurology.. Accessed February 5, 2023 at: https://www.aan.com/PressRoom/home/PressRelease/4974
    PubMed
  • 54 Baldermann JC, Schüller T, Huys D. et al. Deep brain stimulation for Tourette-syndrome: a systematic review and meta-analysis. Brain Stimul 2016; 9 (02) 296-304
    CrossrefPubMedGoogle Scholar
  • 55 Martinez-Ramirez D, Jimenez-Shahed J, Leckman JF. et al. Efficacy and safety of deep brain stimulation in Tourette syndrome: the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry. JAMA Neurol 2018; 75 (03) 353-359
    CrossrefPubMedGoogle Scholar
  • 56 Deeb W, Leentjens AFG, Mogilner AY. et al. Deep brain stimulation lead removal in Tourette syndrome. Parkinsonism Relat Disord 2020; 77: 89-93
    CrossrefPubMedGoogle Scholar
  • 57 Servello D, Sassi M, Brambilla A. et al. De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report. J Neurol 2009; 256 (09) 1533-1539
    CrossrefPubMedGoogle Scholar
  • 58 Schrock LE, Mink JW, Woods DW. et al; Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group. Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord 2015; 30 (04) 448-471
    CrossrefPubMedGoogle Scholar
  • 59 Martino D, Deeb W, Jimenez-Shahed J. et al. The 5 pillars in Tourette syndrome deep brain stimulation patient selection: present and future. Neurology 2021; 96 (14) 664-676
    CrossrefPubMedGoogle Scholar
  • 60 Szejko N, Worbe Y, Hartmann A. et al. European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry [Internet]. 2021 Oct 4 [cited 2022 Jan 29]. Accessed February 5, 2023 at: https://link.springer.com/10.1007/s00787-021-01881-9
    PubMed
  • 61 Edwards MJ, Lang AE, Bhatia KP. Stereotypies: a critical appraisal and suggestion of a clinically useful definition. Mov Disord 2012; 27 (02) 179-185
    CrossrefPubMedGoogle Scholar
  • 62 Harris KM, Mahone EM, Singer HS. Nonautistic motor stereotypies: clinical features and longitudinal follow-up. Pediatr Neurol 2008; 38 (04) 267-272
    CrossrefPubMedGoogle Scholar
  • 63 Melo C, Ruano L, Jorge J. et al. Prevalence and determinants of motor stereotypies in autism spectrum disorder: a systematic review and meta-analysis. Autism 2020; 24 (03) 569-590
    CrossrefPubMedGoogle Scholar
  • 64 Singer HS. Motor stereotypies. Semin Pediatr Neurol 2009; 16 (02) 77-81
    CrossrefPubMedGoogle Scholar
  • 65 Blackburn J, Parnes M. Tics, tremors and other movement disorders in childhood. Curr Probl Pediatr Adolesc Health Care 2021; 51 (03) 100983
    CrossrefPubMedGoogle Scholar
  • 66 Kurlan R. A clinically useful definition of stereotypies. Mov Disord 2013; 28 (03) 404-404
    CrossrefPubMedGoogle Scholar
  • 67 Mainka T, Balint B, Gövert F. et al. The spectrum of involuntary vocalizations in humans: a video atlas. Mov Disord 2019; 34 (12) 1774-1791
    CrossrefPubMedGoogle Scholar
  • 68 Freeman RD, Soltanifar A, Baer S. Stereotypic movement disorder: easily missed. Dev Med Child Neurol 2010; 52 (08) 733-738
    CrossrefPubMedGoogle Scholar
  • 69 Robinson S, Woods M, Cardona F, Baglioni V, Hedderly T. Intense imagery movements: a common and distinct paediatric subgroup of motor stereotypies. Dev Med Child Neurol 2014; 56 (12) 1212-1218
    CrossrefPubMedGoogle Scholar
  • 70 Muthugovindan D, Singer H. Motor stereotypy disorders. Curr Opin Neurol 2009; 22 (02) 131-136
    CrossrefPubMedGoogle Scholar
  • 71 Lam KSL, Aman MG. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders. J Autism Dev Disord 2007; 37 (05) 855-866
    CrossrefPubMedGoogle Scholar
  • 72 Miller JM, Singer HS, Bridges DD, Waranch HR. Behavioral therapy for treatment of stereotypic movements in nonautistic children. J Child Neurol 2006; 21 (02) 119-125
    CrossrefPubMedGoogle Scholar
  • 73 Rojahn J, Matson JL, Lott D, Esbensen AJ, Smalls Y. The Behavior Problems Inventory: an instrument for the assessment of self-injury, stereotyped behavior, and aggression/destruction in individuals with developmental disabilities. J Autism Dev Disord 2001; 31 (06) 577-588
    CrossrefPubMedGoogle Scholar
  • 74 Bodfish JW, Symons FJ, Parker DE, Lewis MH. Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord 2000; 30 (03) 237-243
    CrossrefPubMedGoogle Scholar
  • 75 Goldman S, Wang C, Salgado MW, Greene PE, Kim M, Rapin I. Motor stereotypies in children with autism and other developmental disorders. Dev Med Child Neurol 2009; 51 (01) 30-38
    CrossrefPubMedGoogle Scholar
  • 76 Gal E, Dyck MJ, Passmore A. The relationship between stereotyped movements and self-injurious behavior in children with developmental or sensory disabilities. Res Dev Disabil 2009; 30 (02) 342-352
    CrossrefPubMedGoogle Scholar
  • 77 Singer HS. . Stereotypic movement disorders. In: Handbook of Clinical Neurology [Internet]. Elsevier; 2011:631–639. Accessed February 5, 2023 at: https://linkinghub.elsevier.com/retrieve/pii/B9780444520142000458
  • 78 Ghosh D, Rajan PV, Erenberg G. A comparative study of primary and secondary stereotypies. J Child Neurol 2013; 28 (12) 1562-1568
    CrossrefPubMedGoogle Scholar
  • 79 Baranek GT. Autism during infancy: a retrospective video analysis of sensory-motor and social behaviors at 9-12 months of age. J Autism Dev Disord 1999; 29 (03) 213-224
    CrossrefPubMedGoogle Scholar
  • 80 Loh A, Soman T, Brian J. et al. Stereotyped motor behaviors associated with autism in high-risk infants: a pilot videotape analysis of a sibling sample. J Autism Dev Disord 2007; 37 (01) 25-36
    CrossrefPubMedGoogle Scholar
  • 81 Mahone EM, Bridges D, Prahme C, Singer HS. Repetitive arm and hand movements (complex motor stereotypies) in children. J Pediatr 2004; 145 (03) 391-395
    CrossrefPubMedGoogle Scholar
  • 82 Janković SM, Sokić DV, Vojvodić NM, Ristić AJ, Kostić VS. Multiple rhythmic movement disorders in a teenage boy with excellent response to clonazepam. Mov Disord 2008; 23 (05) 767-768
    CrossrefPubMedGoogle Scholar
  • 83 Gwyther ARM, Walters AS, Hill CM. Rhythmic movement disorder in childhood: an integrative review. Sleep Med Rev 2017; 35: 62-75
    CrossrefPubMedGoogle Scholar
  • 84 Oakley C, Mahone EM, Morris-Berry C, Kline T, Singer HS. Primary complex motor stereotypies in older children and adolescents: clinical features and longitudinal follow-up. Pediatr Neurol 2015; 52 (04) 398-403 .e1
    CrossrefPubMedGoogle Scholar
  • 85 Sallustro F, Atwell CW. Body rocking, head banging, and head rolling in normal children. J Pediatr 1978; 93 (04) 704-708
    CrossrefPubMedGoogle Scholar
  • 86 Foster LG. Nervous habits and stereotyped behaviors in preschool children. J Am Acad Child Adolesc Psychiatry 1998; 37 (07) 711-717
    CrossrefPubMedGoogle Scholar
  • 87 Neul JL. The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues Clin Neurosci 2012; 14 (03) 253-262
    CrossrefPubMedGoogle Scholar
  • 88 Fehr S, Downs J, Bebbington A, Leonard H. Atypical presentations and specific genotypes are associated with a delay in diagnosis in females with Rett syndrome. Am J Med Genet A 2010; 152A (10) 2535-2542
    CrossrefPubMedGoogle Scholar
  • 89 Goldman S, Temudo T. Hand stereotypies distinguish Rett syndrome from autism disorder. Mov Disord 2012; 27 (08) 1060-1062
    CrossrefPubMedGoogle Scholar
  • 90 Stallworth JL, Dy ME, Buchanan CB. et al. Hand stereotypies: lessons from the Rett Syndrome Natural History Study. Neurology 2019; 92 (22) e2594-e2603
    CrossrefPubMedGoogle Scholar
  • 91 Prioni S, Fetoni V, Barocco F. et al. Stereotypic behaviors in degenerative dementias. J Neurol 2012; 259 (11) 2452-2459
    CrossrefPubMedGoogle Scholar
  • 92 Jurecka A, Zikanova M, Kmoch S, Tylki-Szymańska A. Adenylosuccinate lyase deficiency. J Inherit Metab Dis 2015; 38 (02) 231-242
    CrossrefPubMedGoogle Scholar
  • 93 Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 2013; 28 (04) 543-547
    CrossrefPubMedGoogle Scholar
  • 94 Brust JCM. Substance abuse and movement disorders. Mov Disord 2010; 25 (13) 2010-2020
    CrossrefPubMedGoogle Scholar
  • 95 Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. . Tremor Other Hyperkinet Mov (N Y) 2013;3:tre-03-161-4138-1
    PubMedGoogle Scholar
  • 96 Fasano A, Petrovic I. Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 2010; 15 (06) 560-573
    CrossrefPubMedGoogle Scholar
  • 97 Fasano A, Evans AH. Is punding a stereotypy?. Mov Disord 2013; 28 (03) 404-405
    CrossrefPubMedGoogle Scholar
  • 98 Fasano A, Ricciardi L, Pettorruso M, Bentivoglio AR. Management of punding in Parkinson's disease: an open-label prospective study. J Neurol 2011; 258 (04) 656-660
    CrossrefPubMedGoogle Scholar
  • 99 Specht MW, Mahone EM, Kline T. et al. Efficacy of parent-delivered behavioral therapy for primary complex motor stereotypies. Dev Med Child Neurol 2017; 59 (02) 168-173
    CrossrefPubMedGoogle Scholar
  • 100 Singer HS, Rajendran S, Waranch HR, Mahone EM. Home-based, therapist-assisted, therapy for young children with primary complex motor stereotypies. Pediatr Neurol 2018; 85: 51-57
    CrossrefPubMedGoogle Scholar
  • 101 Lemmon ME, Gregas M, Jeste SS. Risperidone use in autism spectrum disorders: a retrospective review of a clinic-referred patient population. J Child Neurol 2011; 26 (04) 428-432
    CrossrefPubMedGoogle Scholar
  • 102 Rajapakse T, Pringsheim T. Pharmacotherapeutics of Tourette syndrome and stereotypies in autism. Semin Pediatr Neurol 2010; 17 (04) 254-260
    CrossrefPubMedGoogle Scholar
  • 103 McDougle CJA, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996; 53 (11) 1001-1008
    CrossrefPubMedGoogle Scholar
  • 104 Hollander E, Soorya L, Chaplin W. et al. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry 2012; 169 (03) 292-299 [ Erratum in: Am J Psychiatry. 2012;169(5):540. PMID: 22193531]
    CrossrefPubMedGoogle Scholar
  • 105 Barahona-Corrêa JB, Velosa A, Chainho A, Lopes R, Oliveira-Maia AJ. Repetitive transcranial magnetic stimulation for treatment of autism spectrum disorder: a systematic review and meta-analysis. Front Integr Nuerosci 2018; 12: 27
    CrossrefPubMedGoogle Scholar
  • 106 Khaleghi A, Zarafshan H, Vand SR, Mohammadi MR. Effects of non-invasive neurostimulation on autism spectrum disorder: a systematic review. Clin Psychopharmacol Neurosci 2020; 18 (04) 527-552
    CrossrefPubMedGoogle Scholar
  • 107 Lohr JB, Eidt CA, Abdulrazzaq Alfaraj A, Soliman MA. The clinical challenges of akathisia. CNS Spectr 2015; 20 (Suppl, quiz 15–16 (Suppl. 01) 1-14
    CrossrefPubMedGoogle Scholar
  • 108 Sachdev P. The development of the concept of akathisia: a historical overview. Schizophr Res 1995; 16 (01) 33-45
    CrossrefPubMedGoogle Scholar
  • 109 Barnes TRE. The Barnes Akathisia Rating Scale--revisited. J Psychopharmacol 2003; 17 (04) 365-370
    CrossrefPubMedGoogle Scholar
  • 110 Leong GB, Silva JA. Neuroleptic-induced akathisia and violence: a review. J Forensic Sci 2003; 48 (01) 187-189
    CrossrefPubMedGoogle Scholar
  • 111 Hansen L. A critical review of akathisia, and its possible association with suicidal behaviour. Hum Psychopharmacol 2001; 16 (07) 495-505
    CrossrefPubMedGoogle Scholar
  • 112 Lohr J, Browning J. Movement disorders in neuropsychiatry. Curr Opin Psychiatry 1996; 9 (01) 85-88
    CrossrefPubMedGoogle Scholar
  • 113 Pringsheim T, Barnes TRE. Antipsychotic drug-induced movement disorders: A forgotten problem?. Can J Psychiatry 2018; 63 (11) 717-718
    CrossrefPubMedGoogle Scholar
  • 114 Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 2001; 158 (03) 360-369
    CrossrefPubMedGoogle Scholar
  • 115 Sachdev P. The epidemiology of drug-induced akathisia: Part I. Acute akathisia. Schizophr Bull 1995; 21 (03) 431-449
    CrossrefPubMedGoogle Scholar
  • 116 Halstead SM, Barnes TRE, Speller JC. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry 1994; 164 (02) 177-183
    CrossrefPubMedGoogle Scholar
  • 117 Barnes TR, Braude WM. Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 1985; 42 (09) 874-878
    CrossrefPubMedGoogle Scholar
  • 118 Burke RE, Kang UJ, Jankovic J, Miller LG, Fahn S. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord 1989; 4 (02) 157-175
    CrossrefPubMedGoogle Scholar
  • 119 Åberg K, Adkins DE, Bukszár J. et al. Genome wide association study of movement-related adverse antipsychotic effects. Biol Psychiatry 2010; 67 (03) 279-282
    CrossrefPubMedGoogle Scholar
  • 120 Chauhan G, Nayar P, Kashyap C. Metoclopramide-induced akathisia. J Anaesthesiol Clin Pharmacol 2012; 28 (04) 548-549
    CrossrefPubMedGoogle Scholar
  • 121 Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother 2011; 11 (11) 1509-1523
    CrossrefPubMedGoogle Scholar
  • 122 Hawthorne JM, Caley CF. Extrapyramidal reactions associated with serotonergic antidepressants. Ann Pharmacother 2015; 49 (10) 1136-1152
    CrossrefPubMedGoogle Scholar
  • 123 Lai CH. Venlafaxine-related akathisia side-effects and management in a depressed patient. Psychiatry Clin Neurosci 2013; 67 (02) 127-128
    CrossrefPubMedGoogle Scholar
  • 124 Daniel JR, Mauro VF. Extrapyramidal symptoms associated with calcium-channel blockers. Ann Pharmacother 1995; 29 (01) 73-75
    CrossrefPubMedGoogle Scholar
  • 125 Demir B, Sancaktar M, Altindag A. Lithium-induced treatment-resistant akathisia: a case report and literature overview. Clin Neuropharmacol 2021; 44 (03) 112-113
    CrossrefPubMedGoogle Scholar
  • 126 Dag E, Gokce B, Buturak SV, Tiryaki D, Erdemoglu AK. Pregabalin-induced akathisia. Ann Pharmacother 2013; 47 (04) 592-593
    CrossrefPubMedGoogle Scholar
  • 127 Poewe W, Högl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 2004; 63 (8, Suppl 3): S12-S16
    CrossrefPubMedGoogle Scholar
  • 128 Stewart JT. Akathisia following traumatic brain injury: treatment with bromocriptine. J Neurol Neurosurg Psychiatry 1989; 52 (10) 1200-1201
    CrossrefPubMedGoogle Scholar
  • 129 Seo MW, Shin BS. A case of post-stroke rhythmic akathisia. Ann Clin Neurophysiol 2002; 4 (02) 133-136
    PubMedGoogle Scholar
  • 130 Stuppaeck CH, Miller CH, Ehrmann H, Fleischhacker WW, Felber S, Poewe W. Akathisia induced by necrosis of the basal ganglia after carbon monoxide intoxication. Mov Disord 1995; 10 (02) 229-231
    CrossrefPubMedGoogle Scholar
  • 131 Salem H, Nagpal C, Pigott T, Teixeira AL. Revisiting antipsychotic-induced akathisia: current issues and prospective challenges. Curr Neuropharmacol 2017; 15 (05) 789-798
    CrossrefPubMedGoogle Scholar
  • 132 Pringsheim T, Gardner D, Addington D. et al. The assessment and treatment of antipsychotic-induced akathisia. Can J Psychiatry 2018; 63 (11) 719-729
    CrossrefPubMedGoogle Scholar
  • 133 Kim A, Adler L, Angrist B, Rotrosen J. Efficacy of low-dose metoprolol in neuroleptic-induced akathisia. J Clin Psychopharmacol 1989; 9 (04) 294-296
    PubMedGoogle Scholar
  • 134 Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biol Psychiatry 2006; 59 (11) 1071-1077
    CrossrefPubMedGoogle Scholar
  • 135 Shams-Alizadeh N, Maroufi A, Asadi Z, Rahmani K, Hassanzadeh K. Trazodone as an alternative treatment for neuroleptic-associated akathisia: a placebo-controlled, double-blind, clinical trial. J Clin Psychopharmacol 2020; 40 (06) 611-614
    CrossrefPubMedGoogle Scholar
  • 136 Avital A, Gross-Isseroff R, Stryjer R, Hermesh H, Weizman A, Shiloh R. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study. Eur Neuropsychopharmacol 2009; 19 (07) 476-482
    CrossrefPubMedGoogle Scholar
  • 137 Miodownik C, Lerner V, Statsenko N. et al. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study. Clin Neuropharmacol 2006; 29 (02) 68-72
    CrossrefPubMedGoogle Scholar
  • 138 DiMascio A, Bernardo DL, Greenblatt DJ, Marder JE. A controlled trial of amantadine in drug-induced extrapyramidal disorders. Arch Gen Psychiatry 1976; 33 (05) 599-602
    CrossrefPubMedGoogle Scholar
  • 139 Zubenko GS, Barreira P, Lipinski Jr JF. Development of tolerance to the therapeutic effect of amantadine on akathisia. J Clin Psychopharmacol 1984; 4 (04) 218-220
    CrossrefPubMedGoogle Scholar
  • 140 Zubenko GS, Cohen BM, Lipinski Jr JF, Jonas JM. Use of clonidine in treating neuroleptic-induced akathisia. Psychiatry Res 1984; 13 (03) 253-259
    CrossrefPubMedGoogle Scholar
  • 141 Kutcher S, Williamson P, MacKenzie S, Marton P, Ehrlich M. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study. J Clin Psychopharmacol 1989; 9 (06) 403-406
    CrossrefPubMedGoogle Scholar
  • 142 Adler LA, Peselow E, Rosenthal M, Angrist B. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis. Psychopharmacol Bull 1993; 29 (02) 283-286
    PubMedGoogle Scholar
  • 143 Sachdev P, Loneragan C. Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia. Clin Neuropharmacol 1993; 16 (04) 324-331
    CrossrefPubMedGoogle Scholar
  • 144 Friis T, Christensen TR, Gerlach J. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo. Acta Psychiatr Scand 1983; 67 (03) 178-187
    CrossrefPubMedGoogle Scholar
  • 145 Hirose S, Ashby CR. Intravenous biperiden in akathisia: an open pilot study. Int J Psychiatry Med 2000; 30 (02) 185-194
    CrossrefPubMedGoogle Scholar
  • 146 Lerner V, Bergman J, Statsenko N, Miodownik C. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2004; 65 (11) 1550-1554
    CrossrefPubMedGoogle Scholar
  • 147 Comella CL, Goetz CG. Akathisia in Parkinson's disease. Mov Disord 1994; 9 (05) 545-549
    CrossrefPubMedGoogle Scholar
  • 148 Witjas T, Kaphan E, Azulay JP. et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002; 59 (03) 408-413
    CrossrefPubMedGoogle Scholar
  • 149 Aykaç Ö, Durmaz Çelik FN, Yılmaz R, Bayram E, Akbostanci MC, Karan ŞO. . Akathisia in Parkinson's Disease: A Comparative Cross-Sectional Study. TND; 2021
  • 150 Shin HW, Chang JW, Kang SY, Sohn YH. Effects of chronic subthalamic stimulation on intractable akathisia in Parkinson's disease. Mov Disord 2010; 25 (05) 650-652
    CrossrefPubMedGoogle Scholar
  • 151 Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med 2009; 266 (05) 419-431
    CrossrefPubMedGoogle Scholar
  • 152 Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4 (02) 101-119
    PubMedGoogle Scholar
  • 153 Allen RP, Picchietti DL, Garcia-Borreguero D. et al; International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 2014; 15 (08) 860-873
    CrossrefPubMedGoogle Scholar
  • 154 Kerr S, McKinon W, Bentley A. Descriptors of restless legs syndrome sensations. Sleep Med 2012; 13 (04) 409-413
    CrossrefPubMedGoogle Scholar
  • 155 Bassetti CL, Mauerhofer D, Gugger M, Mathis J, Hess CW. Restless legs syndrome: a clinical study of 55 patients. Eur Neurol 2001; 45 (02) 67-74
    CrossrefPubMedGoogle Scholar
  • 156 Michaud M, Lavigne G, Desautels A, Poirier G, Montplaisir J. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord 2002; 17 (01) 112-115
    CrossrefPubMedGoogle Scholar
  • 157 Hornyak M, Feige B, Voderholzer U, Philipsen A, Riemann D. Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep 2007; 30 (07) 861-865
    CrossrefPubMedGoogle Scholar
  • 158 Allen RP, Stillman P, Myers AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in Western Europe: prevalence and characteristics. Sleep Med 2010; 11 (01) 31-37
    CrossrefPubMedGoogle Scholar
  • 159 Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12 (01) 61-65
    CrossrefPubMedGoogle Scholar
  • 160 Garcia-Borreguero D, Kohnen R, Boothby L, Tzonova D, Larrosa O, Dunkl E. Validation of the multiple suggested immobilization test: a test for the assessment of severity of restless legs syndrome (Willis-Ekbom disease). Sleep 2013; 36 (07) 1101-1109
    CrossrefPubMedGoogle Scholar
  • 161 Walters AS, LeBrocq C, Dhar A. et al; International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4 (02) 121-132
    CrossrefPubMedGoogle Scholar
  • 162 Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 2012; 16 (04) 283-295
    CrossrefPubMedGoogle Scholar
  • 163 Winkelmann J, Muller-Myhsok B, Wittchen HU. et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002; 52 (03) 297-302
    CrossrefPubMedGoogle Scholar
  • 164 Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008; 70 (01) 35-42
    CrossrefPubMedGoogle Scholar
  • 165 Calhoun DA, Harding SM. Sleep and hypertension. Chest 2010; 138 (02) 434-443
    CrossrefPubMedGoogle Scholar
  • 166 Gao X, Schwarzschild MA, O'Reilly EJ, Wang H, Ascherio A. Restless legs syndrome and erectile dysfunction. Sleep 2010; 33 (01) 75-79
    CrossrefPubMedGoogle Scholar
  • 167 Kurt O, Yazici CM, Alp R, Sancak EB, Topcu B. Is it only a sleeping disorder or more? Restless legs syndrome and erectile function. Scand J Urol 2016; 50 (05) 392-395
    CrossrefPubMedGoogle Scholar
  • 168 Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005; 28 (07) 891-898
    PubMedGoogle Scholar
  • 169 Zhang C, Li Y, Malhotra A, Ning Y, Gao X. Restless legs syndrome status as a predictor for lower physical function. Neurology 2014; 82 (14) 1212-1218
    CrossrefPubMedGoogle Scholar
  • 170 Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006; 67 (01) 125-130
    CrossrefPubMedGoogle Scholar
  • 171 Allen RP, Auerbach S, Bahrain H, Auerbach M, Earley CJ. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol 2013; 88 (04) 261-264
    CrossrefPubMedGoogle Scholar
  • 172 Novak M, Winkelman JW, Unruh M. Restless legs syndrome in patients with chronic kidney disease. Semin Nephrol 2015; 35 (04) 347-358
    CrossrefPubMedGoogle Scholar
  • 173 Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Association between restless legs syndrome and peripheral neuropathy: a systematic review and meta-analysis. Eur J Neurol 2021; 28 (07) 2423-2442
    CrossrefPubMedGoogle Scholar
  • 174 Manconi M, Govoni V, De Vito A. et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004; 5 (03) 305-308
    CrossrefPubMedGoogle Scholar
  • 175 Patatanian E, Claborn MK. Drug-induced restless legs syndrome. Ann Pharmacother 2018; 52 (07) 662-672
    CrossrefPubMedGoogle Scholar
  • 176 Iranzo A, Comella CL, Santamaria J, Oertel W. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Mov Disord 2007; 22 (Suppl (Suppl. 18) S424-S430
    CrossrefPubMedGoogle Scholar
  • 177 Allen RP, Picchietti DL, Auerbach M. et al; International Restless Legs Syndrome Study Group (IRLSSG). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med 2018; 41: 27-44
    CrossrefPubMedGoogle Scholar
  • 178 Silber MH, Buchfuhrer MJ, Earley CJ, Koo BB, Manconi M, Winkelman JW. Scientific and Medical Advisory Board of the Restless Legs Syndrome Foundation. The management of restless legs syndrome: an updated algorithm. Mayo Clin Proc 2021; 96 (07) 1921-1937
    CrossrefPubMedGoogle Scholar
  • 179 Walters AS, Ondo WG, Kushida CA. et al; XP045 Study Group. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial. Clin Neuropharmacol 2009; 32 (06) 311-320
    CrossrefPubMedGoogle Scholar
  • 180 Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW. XP053 Study Group. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med 2011; 7 (03) 282-292
    CrossrefPubMedGoogle Scholar
  • 181 Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW. XP052 Study Group. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS. Neurology 2009; 72 (05) 439-446
    CrossrefPubMedGoogle Scholar
  • 182 Garcia-Borreguero D, Patrick J, DuBrava S. et al. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome. Sleep 2014; 37 (04) 635-643
    CrossrefPubMedGoogle Scholar
  • 183 Garcia-Borreguero D, Larrosa O, Williams AM. et al. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology 2010; 74 (23) 1897-1904
    CrossrefPubMedGoogle Scholar
  • 184 Allen R, Chen C, Soaita A. et al. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. Sleep Med 2010; 11 (06) 512-519
    CrossrefPubMedGoogle Scholar
  • 185 Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999; 52 (05) 938-943
    CrossrefPubMedGoogle Scholar
  • 186 Liu GJ, Wu L, Lin Wang S, Xu LL, Ying Chang L, Fu Wang Y. Efficacy of pramipexole for the treatment of primary restless leg syndrome: a systematic review and meta-analysis of randomized clinical trials. Clin Ther 2016; 38 (01) 162-179 .e6
    CrossrefPubMedGoogle Scholar
  • 187 Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY. TREAT RLS US Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2006; 81 (01) 17-27
    CrossrefPubMedGoogle Scholar
  • 188 Trenkwalder C, Garcia-Borreguero D, Montagna P. et al; Therapy with Ropiunirole; Efficacy and Tolerability in RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004; 75 (01) 92-97
    PubMedGoogle Scholar
  • 189 Montplaisir J, Karrasch J, Haan J, Volc D. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord 2006; 21 (10) 1627-1635
    CrossrefPubMedGoogle Scholar
  • 190 Hening WA, Allen RP, Ondo WG. et al; SP792 Study Group. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord 2010; 25 (11) 1675-1683
    CrossrefPubMedGoogle Scholar
  • 191 Trenkwalder C, Beneš H, Poewe W. et al; SP790 Study Group. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008; 7 (07) 595-604
    CrossrefPubMedGoogle Scholar
  • 192 de Oliveira CO, Carvalho LB, Carlos K. et al. Opioids for restless legs syndrome. Cochrane Movement Disorders Group, ed. Cochrane Database of Systematic Reviews. 2016;2016(8). doi: DOI: 10.1002/14651858.CD006941.pub2
    Crossref
  • 193 Garcia-Borreguero D, Garcia-Malo C, Granizo JJ, Ferré S. A randomized, placebo-controlled crossover study with dipyridamole for restless legs syndrome. Mov Disord 2021; 36 (10) 2387-2392
    CrossrefPubMedGoogle Scholar
  • 194 Garcia-Borreguero D, Cano I, Granizo JJ. Treatment of restless legs syndrome with the selective AMPA receptor antagonist perampanel. Sleep Med 2017; 34: 105-108
    CrossrefPubMedGoogle Scholar
  • 195 Klepitskaya O, Liu Y, Sharma S, Sillau SH, Tsai J, Walters AS. Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease. Neurology 2018; 91 (11) e1013 –e1021
    CrossrefPubMedGoogle Scholar
  • 196 Adil SM, Han JL, Parente BA, Hickey P, Lad SP. Spinal cord stimulation for restless legs syndrome: case series and mechanistic hypothesis. Stereotact Funct Neurosurg 2019; 97 (01) 31-36
    CrossrefPubMedGoogle Scholar
  • 197 Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2006; 19 (05) 487-493
    CrossrefPubMedGoogle Scholar
  • 198 Bega D, Malkani R. Alternative treatment of restless legs syndrome: an overview of the evidence for mind-body interventions, lifestyle interventions, and neutraceuticals. Sleep Med 2016; 17: 99-105
    CrossrefPubMedGoogle Scholar
  • 199 Temudo T, Freitas P, Sequeiros J, Maciel P, Oliveira G. Atypical stereotypies and vocal tics in Rett syndrome: an illustrative case. Mov Disord 2008; 23 (04) 622-624
    CrossrefPubMedGoogle Scholar
  • 200 Schneider SA, Robertson MM, Rizzo R, Turk J, Bhatia KP, Orth M. Fragile X syndrome associated with tic disorders. Mov Disord 2008; 23 (08) 1108-1112
    CrossrefPubMedGoogle Scholar
  • 201 Jinnah HA, Lewis RF, Visser JE, Eddey GE, Barabas G, Harris JC. Ocular motor dysfunction in Lesch-Nyhan disease. Pediatr Neurol 2001; 24 (03) 200-204
    CrossrefPubMedGoogle Scholar
  • 202 Hebebrand J, Martin M, Körner J. et al. Partial trisomy 16p in an adolescent with autistic disorder and Tourette's syndrome. Am J Med Genet 1994; 54 (03) 268-270
    CrossrefPubMedGoogle Scholar
  • 203 Balint B, Wiethoff S, Martino D. et al. Quick flicks: association of paroxysmal kinesigenic dyskinesia and tics. Mov Disord Clin Pract (Hoboken) 2018; 5 (03) 317-320
    CrossrefPubMedGoogle Scholar
  • 204 Mainka T, Fischer JF, Huebl J. et al. The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria. Parkinsonism Relat Disord 2021; 89: 167-175
    CrossrefPubMedGoogle Scholar
  • 205 Saiki S, Hirose G, Sakai K. et al. Chorea-acanthocytosis associated with Tourettism. Mov Disord 2004; 19 (07) 833-836
    CrossrefPubMedGoogle Scholar
  • 206 Looi I, Eow GB, Norlia AM, Santhi DP. Neuroacanthocytosis: a rare inherited movement disorder. Med J Malaysia 2008; 63 (02) 157-158
    PubMedGoogle Scholar
  • 207 Dulski J, Sołtan W, Schinwelski M. et al. Clinical variability of neuroacanthocytosis syndromes-a series of six patients with long follow-up. Clin Neurol Neurosurg 2016; 147: 78-83
    CrossrefPubMedGoogle Scholar
  • 208 Mendez MF, Shapira JS. The spectrum of recurrent thoughts and behaviors in frontotemporal dementia. CNS Spectr 2008; 13 (03) 202-208
    CrossrefPubMedGoogle Scholar
  • 209 Nardocci N, Rumi V, Combi ML, Angelini L, Mirabile D, Bruzzone MG. Complex tics, stereotypies, and compulsive behavior as clinical presentation of a juvenile progressive dystonia suggestive of Hallervorden-Spatz disease. Mov Disord 1994; 9 (03) 369-371
    CrossrefPubMedGoogle Scholar
  • 210 Carod-Artal FJ, Vargas AP, Marinho PB, Fernandes-Silva TV, Portugal D. Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome). [in Spanish]. Rev Neurol 2004; 38 (04) 327-331
    PubMedGoogle Scholar
  • 211 Molina M, Fekete R. Stereotypic movements in case of sporadic Creutzfeldt-Jakob disease: possible role of anti-NMDA receptor antibodies. Case Rep Neurol 2012; 4 (03) 244-247
    CrossrefPubMedGoogle Scholar
  • 212 Kwak CH, Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord 2002; 17 (04) 821-825
    CrossrefPubMedGoogle Scholar
  • 213 Gomis M, Puente V, Pont-Sunyer C, Oliveras C, Roquer J. Adult onset simple phonic tic after caudate stroke. Mov Disord 2008; 23 (05) 765-766
    CrossrefPubMedGoogle Scholar
  • 214 Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol 2013; 12 (06) 597-608
    CrossrefPubMedGoogle Scholar
  • 215 Yochelson MR, David RG. New-onset tic disorder following acute hemorrhage of an arteriovenous malformation. J Child Neurol 2000; 15 (11) 769-771
    CrossrefPubMedGoogle Scholar
  • 216 Badenoch J, Searle T, Watson I, Cavanna AE. Tics in patients with encephalitis. Neurol Sci 2021; 42 (04) 1311-1323
    CrossrefPubMedGoogle Scholar
  • 217 Cardoso F. . Sydenham's chorea. In: Handbook of Clinical Neurology [Internet]. Elsevier; 2011:221–229. Accessed February 5, 2023 at: https://linkinghub.elsevier.com/retrieve/pii/B9780444520142000148
  • 218 Nociti V, Fasano A, Bentivoglio AR. et al. Tourettism in multiple sclerosis: a case report. J Neurol Sci 2009; 287 (1-2): 288-290
    CrossrefPubMedGoogle Scholar
  • 219 Budman C, Sarcevic A. An unusual case of motor and vocal tics with obsessive-compulsive symptoms in a young adult with Behcet's syndrome. CNS Spectr 2002; 7 (12) 878-881
    CrossrefPubMedGoogle Scholar
  • 220 Martino D, Chew NK, Mir P, Edwards MJ, Quinn NP, Bhatia KP. Atypical movement disorders in antiphospholipid syndrome. Mov Disord 2006; 21 (07) 944-949
    CrossrefPubMedGoogle Scholar
  • 221 Krauss JK, Jankovic J. Tics secondary to craniocerebral trauma. Mov Disord 1997; 12 (05) 776-782
    CrossrefPubMedGoogle Scholar
  • 222 Majumdar A, Appleton RE. Delayed and severe but transient Tourette syndrome after head injury. Pediatr Neurol 2002; 27 (04) 314-317
    CrossrefPubMedGoogle Scholar
  • 223 Factor SA, Molho ES. Adult-onset tics associated with peripheral injury. Mov Disord 1997; 12 (06) 1052-1055
    CrossrefPubMedGoogle Scholar
  • 224 Pascual-Leone A, Dhuna A. Cocaine-associated multifocal tics. Neurology 1990; 40 (06) 999-1000
    CrossrefPubMedGoogle Scholar
  • 225 Cardoso FEC, Jankovic J. Cocaine-related movement disorders. Mov Disord 1993; 8 (02) 175-178
    CrossrefPubMedGoogle Scholar
  • 226 Kurlan R. . The differential diagnosis of tic disorders. In: Tourette syndrome. Martino D, Leckman JF, eds. New York: Oxford University Press; 2013:395–401
  • 227 Peters J, Vijiaratnam N, Angus-Leppan H. Tics induced by antiepileptic drugs: a pragmatic review. J Neurol 2021; 268 (01) 321-336
    CrossrefPubMedGoogle Scholar
  • 228 Altindag A, Yanik M, Asoglu M. The emergence of tics during escitalopram and sertraline treatment. Int Clin Psychopharmacol 2005; 20 (03) 177-178
    CrossrefPubMedGoogle Scholar
  • 229 Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TTH. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database. BMC Psychiatry 2020; 20 (01) 308
    CrossrefPubMedGoogle Scholar
  • 230 Baizabal-Carvallo JF, Jankovic J. The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry 2014; 85 (05) 573-575
    CrossrefPubMedGoogle Scholar
  • 231 Demartini B, Ricciardi L, Parees I, Ganos C, Bhatia KP, Edwards MJ. A positive diagnosis of functional (psychogenic) tics. Eur J Neurol 2015; 22 (03) 527-e36
    CrossrefPubMedGoogle Scholar
  • 232 Shapiro E, Shapiro AK, Fulop G. et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989; 46 (08) 722-730
    CrossrefPubMedGoogle Scholar
  • 233 Wijemanne S, Wu LJC, Jankovic J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord 2014; 29 (01) 126-130
    CrossrefPubMedGoogle Scholar
  • 234 Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002; 22 (01) 31-39
    CrossrefPubMedGoogle Scholar
  • 235 Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003; 60 (07) 1130-1135
    CrossrefPubMedGoogle Scholar
  • 236 Wenzel C, Kleimann A, Bokemeyer S, Müller-Vahl KR. Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients. J Clin Psychopharmacol 2012; 32 (04) 548-550
    CrossrefPubMedGoogle Scholar
  • 237 Yoo HK, Joung YS, Lee JS. et al. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder. J Clin Psychiatry 2013; 74 (08) e772-e780
    CrossrefPubMedGoogle Scholar
  • 238 Sallee F, Kohegyi E, Zhao J. et al. Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette's disorder in children and adolescents. J Child Adolesc Psychopharmacol 2017; 27 (09) 771-781
    CrossrefPubMedGoogle Scholar
  • 239 Scahill L, Chappell PB, Kim YS. et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158 (07) 1067-1074
    CrossrefPubMedGoogle Scholar
  • 240 Cummings DD, Singer HS, Krieger M, Miller TL, Mahone EM. Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 2002; 25 (06) 325-332
    CrossrefPubMedGoogle Scholar
  • 241 Murphy TK, Fernandez TV, Coffey BJ. et al. Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders. J Child Adolesc Psychopharmacol 2017; 27 (09) 762-770
    CrossrefPubMedGoogle Scholar
  • 242 Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991; 48 (04) 324-328
    CrossrefPubMedGoogle Scholar
  • 243 Du YS, Li HF, Vance A. et al. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry 2008; 42 (09) 807-813
    CrossrefPubMedGoogle Scholar
  • 244 Eggers C, Rothenberger A, Berghaus U. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988; 237 (04) 223-229
    CrossrefPubMedGoogle Scholar
  • 245 Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010; 81 (01) 70-73
    CrossrefPubMedGoogle Scholar
  • 246 Müller-Vahl KR, Schneider U, Koblenz A. et al. Treatment of Tourette's syndrome with Δ 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry 2002; 35 (02) 57-61
    Article in Thieme ConnectPubMedGoogle Scholar
  • 247 Müller-Vahl KR, Schneider U, Prevedel H. et al. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 2003; 64 (04) 459-465
    CrossrefPubMedGoogle Scholar
  • 248 Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001; 56 (05) 605-610
    CrossrefPubMedGoogle Scholar
  • 249 Zhao L, Li AY, Lv H, Liu FY, Qi FH. Traditional Chinese medicine Ningdong granule: the beneficial effects in Tourette's disorder. J Int Med Res 2010; 38 (01) 169-175
    CrossrefPubMedGoogle Scholar
  • 250 Zheng Y, Zhang ZJ, Han XM. et al. A proprietary herbal medicine (5-Ling granule) for Tourette syndrome: a randomized controlled trial. J Child Psychol Psychiatry 2016; 57 (01) 74-83
    CrossrefPubMedGoogle Scholar
  • 251 Lanzarini E, Pruccoli J, Grimandi I. et al. Phonic and motor stereotypies in autism spectrum disorder: video analysis and neurological characterization. Brain Sci 2021; 11 (04) 431
    CrossrefPubMedGoogle Scholar
  • 252 Collins MSR, Cornish K. A survey of the prevalence of stereotypy, self-injury and aggression in children and young adults with Cri du Chat syndrome. J Intellect Disabil Res 2002; 46 (Pt 2): 133-140
    CrossrefPubMedGoogle Scholar
  • 253 Honjo RS, Mello CB, Pimenta LSE. et al. Cri du Chat syndrome: characteristics of 73 Brazilian patients. J Intellect Disabil Res 2018; 62 (06) 467-473
    CrossrefPubMedGoogle Scholar
  • 254 Huston JC, Thom RP, Ravichandran CT. et al. Repetitive thoughts and repetitive behaviors in Williams syndrome. J Autism Dev Disord 2022; 52 (02) 852-862
    CrossrefPubMedGoogle Scholar
  • 255 Haw CM, Barnes TRE, Clark K, Crichton P, Kohen D. Movement disorder in Down's syndrome: a possible marker of the severity of mental handicap. Mov Disord 1996; 11 (04) 395-403
    CrossrefPubMedGoogle Scholar
  • 256 Boyle L, Kaufmann WE. The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin Med Genet 2010; 154C (04) 469-476
    CrossrefPubMedGoogle Scholar
  • 257 Plazzi G, Pizza F, Palaia V. et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011; 134 (Pt 12): 3477-3489
    CrossrefPubMedGoogle Scholar
  • 258 Gropman AL, Duncan WC, Smith ACM. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatr Neurol 2006; 34 (05) 337-350
    CrossrefPubMedGoogle Scholar
  • 259 Ciardo F, Salerno C, Curatolo P. Neurologic aspects of adenylosuccinate lyase deficiency. J Child Neurol 2001; 16 (05) 301-308
    PubMedGoogle Scholar
  • 260 Pérez-Dueñas B, Sempere A, Campistol J. et al. Novel features in the evolution of adenylosuccinate lyase deficiency. Eur J Paediatr Neurol 2012; 16 (04) 343-348
    CrossrefPubMedGoogle Scholar
  • 261 Burgard P, Armbruster M, Schmidt E, Rupp A. Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria. Acta Paediatr Suppl 1994; 407 (s407): 108-110
    CrossrefPubMedGoogle Scholar
  • 262 Yorio AA, Mesri JC, Pagano MA, Lera G. Stereotypies in Wilson's disease. Mov Disord 1997; 12 (04) 614-616
    CrossrefPubMedGoogle Scholar
  • 263 Cagnin A, Formentin C, Pompanin S. et al. Simple motor stereotypies are not specific features of behavioural frontotemporal dementia. J Neurol Neurosurg Psychiatry 2014; 85 (08) 945-946
    CrossrefPubMedGoogle Scholar
  • 264 Fekete R. Late onset neurodegeneration with brain-iron accumulation presenting as parkinsonism. Case Rep Neurol Med 2012; 2012: 387095
    PubMedGoogle Scholar
  • 265 Ghika-Schmid F, Ghika J, Regli F, Bogousslavsky J. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci 1997; 146 (02) 109-116
    CrossrefPubMedGoogle Scholar
  • 266 Fazzi E, Lanners J, Danova S. et al. Stereotyped behaviours in blind children. Brain Dev 1999; 21 (08) 522-528
    CrossrefPubMedGoogle Scholar
  • 267 Tröster H, Brambring M, Beelmann A. Prevalence and situational causes of stereotyped behaviors in blind infants and preschoolers. J Abnorm Child Psychol 1991; 19 (05) 569-590
    CrossrefPubMedGoogle Scholar
  • 268 Dale RC, Heyman I, Surtees RA. et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 2004; 89 (07) 604-610
    CrossrefPubMedGoogle Scholar
  • 269 Martinelli P, Rizzo G, Scaglione C, Capellari S. Neurosyphilis orofacial dyskinesia: the candy sign. Mov Disord 2013; 28 (02) 246-247
    CrossrefPubMedGoogle Scholar
  • 270 Dale RC, Webster R, Gill D. Contemporary encephalitis lethargica presenting with agitated catatonia, stereotypy, and dystonia-parkinsonism. Mov Disord 2007; 22 (15) 2281-2284
    CrossrefPubMedGoogle Scholar
  • 271 McGrath CM, Kennedy RE, Hoye W, Yablon SA. Stereotypic movement disorder after acquired brain injury. Brain Inj 2002; 16 (05) 447-451
    CrossrefPubMedGoogle Scholar
  • 272 Fasano A, Barra A, Nicosia P. et al. Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 2008; 96 (1-2): 178-182
    CrossrefPubMedGoogle Scholar
  • 273 Evans AH, Katzenschlager R, Paviour D. et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19 (04) 397-405
    CrossrefPubMedGoogle Scholar
  • 274 Spencer AH, Rickards H, Fasano A, Cavanna AE. The prevalence and clinical characteristics of punding in Parkinson's disease. Mov Disord 2011; 26 (04) 578-586
    CrossrefPubMedGoogle Scholar
  • 275 Weintraub D, Papay K, Siderowf A. Parkinson's Progression Markers Initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 2013; 80 (02) 176-180
    CrossrefPubMedGoogle Scholar
  • 276 Baizabal-Carvallo JF, Jankovic J. Functional (psychogenic) stereotypies. J Neurol 2017; 264 (07) 1482-1487
    CrossrefPubMedGoogle Scholar
  • 277 Poretti A, Limperopoulos C, Roulet-Perez E. et al. Outcome of severe unilateral cerebellar hypoplasia. Dev Med Child Neurol 2010; 52 (08) 718-724
    CrossrefPubMedGoogle Scholar
  • 278 Antelmi E, Plazzi G, Erro R. et al. Intermittent head drops: the differential spectrum. J Neurol Neurosurg Psychiatry 2016; 87 (04) 414-419
    CrossrefPubMedGoogle Scholar
  • 279 Patil S, Tas V. . Sandifer Syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022. Accessed February 5, 2023 at: http://www.ncbi.nlm.nih.gov/books/NBK558906/
  • 280 Gottlob I, Zubcov AA, Wizov SS, Reinecke RD. Head nodding is compensatory in spasmus nutans. Ophthalmology 1992; 99 (07) 1024-1031
    CrossrefPubMedGoogle Scholar
  • 281 Wiese JA, Gentry LR, Menezes AH. Bobble-head doll syndrome: review of the pathophysiology and CSF dynamics. Pediatr Neurol 1985; 1 (06) 361-366
    CrossrefPubMedGoogle Scholar
  • 282 Saracoglu M, Kazan MS, Ozak A, Haspolat S. Bobble-head doll syndrome in a child with suprasellar arachnoid cyst. Mov Disord Clin Pract (Hoboken) 2018; 6 (01) 83-84
    CrossrefPubMedGoogle Scholar
  • 283 Graybiel AM. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008; 31 (01) 359-387
    CrossrefPubMedGoogle Scholar
  • 284 Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J. An overview of behavioral strategies for reducing hand-related stereotypies of persons with severe to profound intellectual and multiple disabilities: 1995-2007. Res Dev Disabil 2009; 30 (01) 20-43
    CrossrefPubMedGoogle Scholar
  • 285 Barry S, Baird G, Lascelles K, Bunton P, Hedderly T. Neurodevelopmental movement disorders - an update on childhood motor stereotypies. [ Review] Dev Med Child Neurol 2011; 53 (11) 979-985
    CrossrefPubMedGoogle Scholar
  • 286 Lydon S, Healy O, O'Reilly M, McCoy A. A systematic review and evaluation of response redirection as a treatment for challenging behavior in individuals with developmental disabilities. Res Dev Disabil 2013; 34 (10) 3148-3158
    CrossrefPubMedGoogle Scholar
  • 287 Colón CL, Ahearn WH. An analysis of treatment integrity of response interruption and redirection. J Appl Behav Anal 2019; 52 (02) 337-354
    CrossrefPubMedGoogle Scholar
  • 288 Dowdy A, Tincani M, Schneider WJ. Evaluation of publication bias in response interruption and redirection: a meta-analysis. J Appl Behav Anal 2020; 53 (04) 2151-2171
    CrossrefPubMedGoogle Scholar
  • 289 Martino D, Hedderly T. Tics and stereotypies: a comparative clinical review. Parkinsonism Relat Disord 2019; 59: 117-124
    CrossrefPubMedGoogle Scholar
  • 290 Jesner OS, Aref-Adib M, Coren E. . Risperidone for autism spectrum disorder. Cochrane Developmental, Psychosocial and Learning Problems Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2010. Accessed February 5, 2023 at: http://doi.wiley.com/10.1002/14651858.CD005040.pub2
    PubMed
  • 291 Pandina GJ, Bossie CA, Youssef E, Zhu Y, Dunbar F. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 2007; 37 (02) 367-373
    CrossrefPubMedGoogle Scholar
  • 292 Miral S, Gencer O, Inal-Emiroglu FN, Baykara B, Baykara A, Dirik E. Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry 2008; 17 (01) 1-8
    CrossrefPubMedGoogle Scholar
  • 293 Marcus RN, Owen R, Kamen L. et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 2009; 48 (11) 1110-1119
    CrossrefPubMedGoogle Scholar
  • 294 Owen R, Sikich L, Marcus RN. et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009; 124 (06) 1533-1540
    CrossrefPubMedGoogle Scholar
  • 295 Hirsch LE, Pringsheim T. . Aripiprazole for autism spectrum disorders (ASD). Cochrane Developmental, Psychosocial and Learning Problems Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2016. Accessed February 5, 2023 at: https://doi.wiley.com/10.1002/14651858.CD009043.pub3
    PubMed
  • 296 Reddihough DS, Marraffa C, Mouti A. et al. Effect of fluoxetine on obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders: a randomized clinical trial. JAMA 2019; 322 (16) 1561-1569
    CrossrefPubMedGoogle Scholar
  • 297 Herscu P, Handen BL, Arnold LE. et al; Autism Speaks Autism Clinical Trials Network. The SOFIA study: negative multi-center study of low dose fluoxetine on repetitive behaviors in children and adolescents with autistic disorder. J Autism Dev Disord 2020; 50 (09) 3233-3244
    CrossrefPubMedGoogle Scholar
  • 298 Gordon CT, Rapoport JL, Hamburger SD, State RC, Mannheim GB. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry 1992; 149 (03) 363-366
    CrossrefPubMedGoogle Scholar
  • 299 Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993; 50 (06) 441-447
    CrossrefPubMedGoogle Scholar
  • 300 Ondo WG. Tetrabenazine treatment for stereotypies and tics associated with dementia. J Neuropsychiatry Clin Neurosci 2012; 24 (02) 208-214
    CrossrefPubMedGoogle Scholar
  • 301 Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997; 48 (02) 358-362
    CrossrefPubMedGoogle Scholar
  • 302 Helvink B, Holroyd S. Buspirone for stereotypic movements in elderly with cognitive impairment. J Neuropsychiatry Clin Neurosci 2006; 18 (02) 242-244
    CrossrefPubMedGoogle Scholar
  • 303 Kashihara K, Imamura T. Amantadine may reverse punding in Parkinson's disease--observation in a patient. Mov Disord 2008; 23 (01) 129-130
    CrossrefPubMedGoogle Scholar